Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients

British Journal of Haematology

Volumn 106, Issue 4, 1999, Pages 1052-1058

  Dürken, Matthias ^a   Horstmann, Martin ^a   Bieling, Patricia ^a   Erttmann, Rudolf ^a   Kabisch, Hartmut ^a   Löliger, Cornelius ^a   Schneider, E Marion ^b   Hellwege, Hans Henning ^a   Krüger, William ^a   Kröger, Nikolaus ^a   Zander, Axel R ^a   Janka, Gritta E ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Active disease; Bone marrow transplantation; Haemophagocytic lymphohistiocytosis; Unrelated donors; Veno occlusive disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN G; METHOTREXATE; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CAPILLARY LEAK SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROPHAGOCYTOSIS; FEMALE; GRAFT VERSUS HOST REACTION; HISTIOCYTOSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0032828591     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01625.x     Document Type: Article

References (34)

1. Adachi, S., Kubota, M., Akiyama, Y., Kato, T., Kitoh, T. & Furusho, K. (1997) Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis. Bone Marrow Transplantation. 19, 183-185.
2. Ambruso, D.R., Hays, T., Zwartjes, W.J., Tubergen, D.G. & Favara, B.E. (1980) Successful treatment of lymphohisticoytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer, 45, 2516-2520.
3. Arico, M., Janka, G., Fischer, A., Henter, J-I., Blanche, S., Elinder, G., Martinetti, M. & Rusca, M.P., for the FHL Study Group of the Histiocyte Society (1996) Hemophagocytic lymphohistiocytosis: report of 122 children from the international registry. Leukemia, 10, 197-203.
4. Baker, K.S., DeLaat, C.A., Steinbuch, M., Gross, T.G., Shapiro, R.S., Loechelt, B., Harris, R. & Filipovich, A.H. (1997) Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood, 89, 3857-3863.
5. Bearman, S.L., Appelbaum, F.R., Buckner, C.D., Petersen, F., Fisher, L.D., Clift, R.A. & Thomas, E.D. (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology. 6, l562-1568.
6. Beelen, D.W., Haralambie, E., Brandt, H., Linzenmeier, G., Müller, K.D., Quabeck, K., Sayer, H.G., Graeven, U., Mahmoud, H.K. & Schaefer, U.W. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood, 80, 2668-2676.
7. Bolme, P., Hunter, J-I., Winiarski, J., Elinder, G., Ljungman, P., Lönnerholm, G. & Ringdén, O. (1995) Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden. Bone Marrow Transplantation, 15, 331-335.
8. Brown, R.E., Bowman, W.P., D'Cruz, C.A., Pick, T.E. & Champion, J.E. (1987) Endoperoxidation, hyperprostaglandinema, and hyperlipidemia in a case of erythrophagocytic lymphohisticoytosis: reversal with VP-16 and indomethacin. Cancer, 60, 2388-2393.
9. Eife, R., Janka, G.E., Belohradsky, B.H. & Holtmann, H. (1989) Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatric Hematology and Oncology. 6, 265-272.
10. Farquhar, J.W. & Claireaux, A.F. (1952) Familial hemophagocytic reticulosis. Archives of Disease in Childhood, 27, 519-525.
11. Fischer, A., Virelizier, J.L., Arenzana-Seisdedos, F., Perez, N., Nezelof, C. & Criscelli, C. (1985) Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation. Pediatrics, 76, 263-268.
12. Fischer, A., Cerf-Bensussan, N., Blanche, S., Le Deist, F., Bremard-Oury, C., Leverger, G., Schaison, G., Durandy, A. & Griscelli, C. (1986) Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. Journal of Pediatrics, 108, 267-270.
13. Glucksberg, H., Storb, R., Fefer, A., Buckner, C., Neiman, P., Clift, R., Lerner, K. & Thomas, E. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched donors. Transplantation, 18, 295-304.
14. Haddad, K., Sulis, M.L., Jabado, N., Blanche, S., Fischer, A. & Tardieu, M. (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood, 89, 794-800.
15. Henter, J.I., Elinder, G., Finkel, Y. & Soder, O. (1986) Successful induction with chemotherapy including teniposide in familial crytrophagocytic lymphohistiocytosis. Lancet, ii. 1402.
16. Henter, J.I., Elinder, G., & Ost, A. (1991a) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of the Histiocyte Society. Seminars in Oncology. 18, 29-33.
17. Henter, J-I., Elinder, G., Söder, O., Hansoon, M., Andersson, B. & Andersson U. (1991b) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 2918-2922.
18. Hirst, W.J.R., Layton, J.M., Singh, S., Mieli-Vergani, G., Chessells, J.M., Strobel, S. & Pritchard, J. (1994) Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. British Journal of Haematology. 88, 731-739.
19. Imashuku, S. & Hibi, S. (1991) Cytokines in haemophagocytic syndrome. British Journal of Haematology, 77, 438-440.
20. Jabado, N., de Graeff-Meeder, E.R., Cavazzana-Calvo, M., Haddad, E., Le Delst, F., Benkerrou, M., Dufourcq, R., Caillat, S., Blanche, S. & Fischer, A. (1997) Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood, 90, 4743-4748.
21. Janka, G.E. (1983) Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 140, 221-230.
22. Ladisch, S., Ho, W., Matheson, D., Pilkington, R. & Hartman, G. (1982) Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood, 60, 814-821.
23. Landman-Parker, J., Le Deist, F., Blaise, A., Brison, O. & Fischer, A. (1993) Partial engraftment.of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. British Journal of Haematology, 85, 37-41.
24. McDonald, G.B., Hinds, M.S., Fisher, L.D., School, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M. & Clift, R.A. (1993) Venoocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine, 118, 255-267.
25. Méresse, V., Hartmann, O., Vassal, G., Benhamou, E., Valteau-Couanet, D., Brugieres, L. & Lemerle, J. (1992) Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplantation, 10, 135-141.
26. Perez, N., Virelizier, J-L., Arenzana-Seisdedos, F., Fischer, A. & Griscelli, C. (1984) Impaired natural killer cell activity in lymphohistiocytosis syndrome. Journal of Pediatrics, 104, 569-573.
27. Poynton, C.H., Jackson, S., Fegan, C., Barnes, R.A. & Whittaker, J.A. (1992) Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplantation, 9, 451-457.
28. Schneider, E.M., Pawelec, G., Shi, L.R. & Wernet, P. (1984) A novel type of human T cell clones with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology. Journal of Immunology. 135, 173-179.
29. Schipper, R.F., D'Amaro, J. & Oudshoorn, M. (1996) The probability of finding a suitable related donor for hone marrow transplantation in extended families. Blood. 87, 800-804.
30. Shulman, H., Sullivan, K., Widen, P., McDonald, G., Striker, G., Sale, G., Hackman, R., Tsoi, M., Storb, R. & Thomas, E. (1980) Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204-217.
31. Stéphan, J.L., Donadieu, J., Ledeist, F., Blanche, S., Griscelli, C. & Fischer, A. (1991) Treatment of familial hemophagocytic lymphohistlocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood, 82, 2319-2323.
32. + cells from an HLA-identical unrelated donor. Bone Marrow Transplantation, 16, 719-722.
33. Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sulivan, K., Witherspoon, R. & Thomas, E.D. (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119-125.
34. Ware, R., Friedman, H.S., Kinney, T.R., Kurtzberg, J., Chaffee, S, & Falletta, J.M. (1990) Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy. Medical and Pediatric Oncology. 18, 27-29.